IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast Featuring Dr. Faz Chowdhury, CEO of Nemaura Medical Inc.
08 août 2022 08h17 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment...
Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding
23 mai 2022 06h30 HE
|
Nemaura Medical, Inc
Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
Nemaura Medical to Present at the Planet MicroCap Showcase 2022
25 avr. 2022 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, April 25, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
Nemaura Medical Appoints Jay L. Warner as Head of U.S. Commercial Operations
01 févr. 2021 08h00 HE
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical To Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
11 janv. 2021 08h00 HE
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Launches BEAT®diabetes Program and Its Novel proBEAT™ Non-Invasive, Daily-Wear Adhesive Glucose Monitor
17 déc. 2020 08h00 HE
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference
11 déc. 2020 09h00 HE
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Launches BEAT™diabetes Program Through New Web Presence and Re-Launches Enhanced Corporate Website
17 nov. 2020 08h00 HE
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at Virtual Diabetes Technology Meeting 2020
22 oct. 2020 08h00 HE
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products
21 sept. 2020 08h00 HE
|
Nemaura Medical Inc.
Clinically proven app from Healthimation, LLC, to be paired with Company’s proBEAT™ non-invasive CGM system solution to offer convenient and effective management of pre-diabetes and Type 2 diabetes ...